PD59-07 RISK FACTORS OF PHARMACOTHERAPY FOR STORAGE SYMPTOMS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | Zendy

AI Assistant Blog Pricing

PD59-07 RISK FACTORS OF PHARMACOTHERAPY FOR STORAGE SYMPTOMS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.